Clinical Trial Update: Safety, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on a buccal film formulation of montelukast for patients with Alzheimer disease, reporting safety and efficacy findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Montelukast buccal film (montelukast)

Snippet

Sponsor: IntelGenx Corp. | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED